Pacific Sun Financial’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$776K Buy
4,126
+20
+0.5% +$3.85K 0.38% 79
2025
Q4
$777K Sell
4,106
-137
-3% -$25.3K 0.37% 77
2025
Q3
$703K Sell
4,243
-150
-3% -$24.5K 0.34% 83
2025
Q2
$673K Sell
4,393
-430
-9% -$64K 0.35% 81
2025
Q1
$759K Sell
4,823
-170
-3% -$27.6K 0.43% 71
2024
Q4
$784K Sell
4,993
-674
-12% -$113K 0.43% 73
2024
Q3
$1.01M Sell
5,667
-150
-3% -$26.6K 0.55% 53
2024
Q2
$980K Sell
5,817
-150
-3% -$24.5K 0.58% 51
2024
Q1
$992K Sell
5,967
-70
-1% -$11.6K 0.58% 52
2023
Q4
$998K Sell
6,037
-52
-0.9% -$8K 0.63% 49
2023
Q3
$948K Sell
6,089
-10
-0.2% -$1.6K 0.66% 46
2023
Q2
$989K Buy
+6,099
New +$974K 0.66% 47
2022
Q4
$974K Sell
6,099
-150
-2% -$23.8K 0.69% 45
2022
Q3
$880K Buy
6,249
+32
+0.5% +$4.84K 0.62% 52
2022
Q2
$906K Sell
6,217
-25
-0.4% -$3.72K 0.6% 53
2022
Q1
$1.01M Sell
6,242
-15
-0.2% -$2.43K 0.55% 58
2021
Q4
$1.19M Sell
6,257
-15
-0.2% -$2.89K 0.63% 51
2021
Q3
$1.27M Buy
+6,272
New +$1.32M 0.73% 46
2020
Q3
$1.04M Buy
6,411
+386
+6% +$62.8K 0.87% 35
2020
Q2
$982K Hold
6,025
0.89% 33
2020
Q1
$771K Sell
6,025
-125
-2% -$16.8K 0.89% 38
2019
Q4
$857K Hold
6,150
0.76% 49
2019
Q3
$726K Sell
6,150
-120
-2% -$14.9K 0.69% 50
2019
Q2
$809K Buy
+6,270
New +$773K 0.77% 49
2018
Q2
$823K Buy
6,272
+680
+12% +$80.1K 0.85% 44
2018
Q1
$673K Buy
+5,592
New +$702K 0.89% 41

Other funds holding BBH

Pacific Sun Financial's BBH Position: Q1 2026 in Review

Pacific Sun Financial increased its VanEck Biotech ETF (BBH) stake by 0.49% in Q1 2026, buying an estimated $3.85K and bringing the position to 4,126 shares worth $776K. The position accounts for 0.38% of the portfolio, ranked #79.

Pacific Sun Financial first reported a position in BBH in Q1 2018 and has held it in 26 quarters since. The position peaked at $1.27M in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Pacific Sun Financial held 4,126 shares of VanEck Biotech ETF worth $776K as of Q1 2026.
  • Pacific Sun Financial bought 20 VanEck Biotech ETF shares in Q1 2026, an estimated $3.85K.
  • VanEck Biotech ETF made up 0.38% of Pacific Sun Financial's portfolio in Q1 2026, its #79 holding.
  • Pacific Sun Financial first reported a position in VanEck Biotech ETF in Q1 2018 and has held it in 26 quarters since.
  • Pacific Sun Financial's VanEck Biotech ETF position peaked at $1.27M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Pacific Sun Financial's 13F filing for Q1 2026, filed 8 May 2026.